Prof. Dr. Nuriye İlknur TUTKUN

Yayın Ağı

Makaleler 162

1. International consensuses and guidelines on managing ocular Behçet’s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI)

Chan V. T., Mak A. C., Agrawal R., Biswas J., Bodaghi B., Chan C. K., et al.

Asia-Pacific Journal of Ophthalmology , cilt.14, sa.6, 2025 (SCI-Expanded, Scopus)

2. Evidence and Consensus-based Imaging Guidelines in Birdshot Chorioretinopathy: Multimodal Imaging in Uveitis (MUV) Taskforce Report 8

PICHI F., MISEROCCHI E., GREWAL D. S., SHARMA S., BRÉZIN A. P., BODAGHI B., et al.

American Journal of Ophthalmology , cilt.278, ss.271-281, 2025 (SCI-Expanded)

3. Noninfectious Uveitis in Pediatric Rheumatology Long-term Follow-up at Tertiary Centers

Akay N., Gul U., Koker O., EROL A., YILDIZ M., Konte E. K., et al.

Journal of Clinical Rheumatology , cilt.31, sa.5, ss.181-187, 2025 (SCI-Expanded)

4. Advances in Understanding the Causes, Management and Outcomes of Acute Retinal Necrosis

Smit D. P., Thorne J. E., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.33, sa.5, ss.711-712, 2025 (SCI-Expanded)

5. Review for Disease of the Year Clinical Features and Ocular Imaging in Intermediate Uveitis and Pars Planitis

Ozdal P. Ç., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.33, sa.4, ss.512-521, 2025 (SCI-Expanded)

6. A Word from the Editors

Smit D. P., Thorne J. E., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.33, sa.1, ss.1, 2025 (SCI-Expanded)

7. Behçet Disease Uveitis: Insights into Epigenetic and Environmental Factors, Retinal Imaging, and Treatment

Tugal-Tutkun I., Smit D. P., Thorne J. E.

Ocular Immunology and Inflammation , cilt.33, sa.8, ss.1511-1512, 2025 (SCI-Expanded)

8. Advances in Understanding the Utility of Adalimumab

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.33, sa.3, ss.329-331, 2025 (SCI-Expanded)

9. Disease of the Year 2024: Intermediate Uveitis

Smit D. P., Thorne J. E., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.33, sa.4, ss.501-502, 2025 (SCI-Expanded)

10. Unusual and Atypical Ocular Infections

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.33, sa.2, ss.189-190, 2025 (SCI-Expanded)

11. The Global Epidemiology of Uveitis: More Pieces of the Puzzle

Smit D. P., Thorne J. E., Tugal-Tutkun I., Kempen J. H.

Ocular Immunology and Inflammation , cilt.33, sa.7, ss.1075-1076, 2025 (SCI-Expanded)

12. The Multifaceted Landscape of Endophthalmitis: Insights and Implications

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.32, sa.6, ss.793-795, 2024 (SCI-Expanded)

13. Correlation between Widefield Fundus Fluorescein Angiography Leakage Score and Anterior Chamber Flare in Behçet Uveitis

Kabaalioglu Guner M., Guner M. E., Oray M., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.32, sa.1, ss.54-61, 2024 (SCI-Expanded)

14. Sarcoid Uveitis

Tugal-Tutkun I., Thorne J. E., Smit D. P.

Ocular Immunology and Inflammation , cilt.32, sa.2, ss.135-136, 2024 (SCI-Expanded)

15. Monkeypox

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.32, sa.3, ss.251-252, 2024 (SCI-Expanded)

16. Editorial 2024

Tugal-Tutkun I., Thorne J. E., Smit D. P.

Ocular Immunology and Inflammation , cilt.32, sa.1, ss.1, 2024 (SCI-Expanded)

17. The Potential Role of Large Language Models in Uveitis Care: Perspectives After ChatGPT and Bard Launch

Tan Yip Ming C., Rojas-Carabali W., Cifuentes-González C., Agrawal R., Thorne J. E., Tugal-Tutkun I., et al.

Ocular Immunology and Inflammation , cilt.32, sa.7, ss.1435-1439, 2024 (SCI-Expanded)

18. The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis

Akhavanrezayat A., Uludag Kirimli G., Matsumiya W., Khojasteh H., Or C., Karaca I., et al.

Ocular Immunology and Inflammation , cilt.32, sa.8, ss.1832-1843, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Cytomegalovirus and the Eye

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.32, sa.5, ss.475-476, 2024 (SCI-Expanded)

20. A case of Bartonellosis mimicking systemic lupus erythematosus

Kara M., Ozdemir G. N., Tasdemir M., Ata S., Karini B., Valiyev E., et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.33, sa.6, 2023 (SCI-Expanded)

21. An Overview of Pediatric Uveitis

Tuğal-Tutkun İ.

Turkish Archives of Pediatrics , cilt.58, sa.4, ss.363-370, 2023 (Scopus)

22. EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

Kuiper J. J. W., Prinz J. C., Stratikos E., Kusnierczyk P., Arakawa A., Springer S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.82, ss.887-896, 2023 (SCI-Expanded)

23. Optical Coherence Tomography Angiography (OCT-A) in Uveitis: A Literature Review and a Reassessment of Its Real Role

Herbort C. P., Takeuchi M., Papasavvas I., Tugal-Tutkun I., Hedayatfar A., Usui Y., et al.

Diagnostics , cilt.13, sa.4, 2023 (SCI-Expanded)

24. Mooren’s Ulcer

Cunningham E. T., Agarwal M., Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.31, sa.4, ss.673-674, 2023 (SCI-Expanded)

25. From the Editors

Tugal-Tutkun I., Smit D. P., Cunningham E. T., Thorne J. E.

Ocular Immunology and Inflammation , cilt.31, sa.6, ss.1115-1116, 2023 (SCI-Expanded)

26. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection

Altan C., Basarir B., Bayraktar S., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.31, sa.6, ss.1163-1168, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Ocular Syphilis

Smit D. P., Cunningham E. T., Thorne J. E., Tugal-Tutkun I.

Ocular Immunology and Inflammation , cilt.31, sa.7, ss.1313-1314, 2023 (SCI-Expanded)

28. Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?

Fragoulis G. E., Bertsias G., Bodaghi B., Gul A., van Laar J., MUMCU G., et al.

Clinical Immunology , cilt.246, 2023 (SCI-Expanded)

29. Disease of the Year for 2023: Pediatric Uveitis

Smit D. P., Tugal-Tutkun I., Thorne J. E.

Ocular Immunology and Inflammation , cilt.31, sa.10, ss.1897-1899, 2023 (SCI-Expanded)

30. Uveitis in Behçet disease - An update

Tugal-Tutkun I.

Current Opinion in Rheumatology , cilt.35, sa.1, ss.17-24, 2023 (SCI-Expanded)

31. Assessment of the Anti-inflammatory Effects of NORFLO (R) ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study

Allegri P., Cimino L., Davis J. L., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.31, sa.3, ss.526-535, 2023 (SCI-Expanded)

32. Familial Mediterranean fever associated frosted branch angiitis, retinal vasculitis and vascular occlusion

Mansour H. A., Ozdal P. C., KADAYIFÇILAR S., Tugal-Tutkun I., ESER ÖZTÜRK H., YALÇINDAĞ F. N., et al.

EYE , cilt.36, sa.11, ss.2157-2162, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Developments in uveitis

Tugal-Tutkun I.

SAUDI JOURNAL OF OPHTHALMOLOGY , cilt.36, sa.4, ss.335-336, 2022 (ESCI)

34. Benefits and Limitations of OCT-A in the Diagnosis and Follow-Up of Posterior Intraocular Inflammation in Current Clinical Practice: A Valuable Tool or a Deceiver?

Herbort C. P., Papasavvas I., Tugal-Tutkun I.

DIAGNOSTICS , cilt.12, sa.10, 2022 (SCI-Expanded)

35. How challenging can it be to treat Behcet uveitis?

ORAY M., CEBECİ Z., KIR N., Tugal-Tutkun I.

SAUDI JOURNAL OF OPHTHALMOLOGY , cilt.36, sa.4, ss.397-399, 2022 (ESCI)

36. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update

Tuğal-Tutkun İ., Altan Ç.

Turkish Journal of Ophthalmology , cilt.52, sa.5, ss.342-347, 2022 (Scopus)

37. Choroidal involvement in systemic vasculitis: a systematic review

Ozdal P. C., Tugal-Tutkun I.

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION , cilt.12, sa.1, 2022 (ESCI)

38. Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis

Papasavvas I., Tugal-Tutkun I., Herbort C. P.

PHARMACEUTICALS , cilt.15, sa.4, 2022 (SCI-Expanded)

39. ANTI-TUBERCULOSIS TREATMENT IN PRESUMED OCULAR TUBERCULOSIS PATIENTS WITH GRANULOMATOSIS OCULAR PATHOLOGIES: SINGLE CENTER EXPERIENCE FROM TURKIYE

Cagatay T., Kilicaslan Z., Pihtili A., Bingol Z., Ray M., Kiyan E., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.85, sa.2, ss.205-210, 2022 (ESCI)

40. "White dot syndromes", an inappropriate and outdated misnomer

Neri P., Herbort C. P., Hedayatfar A., Tugal-Tutkun I., Cimino L., Urzua C. A., et al.

INTERNATIONAL OPHTHALMOLOGY , cilt.42, sa.1, 2022 (SCI-Expanded)

41. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review

Herbort C. P., Tugal-Tutkun I., Abu-El-Asrar A., Gupta A., Takeuchi M., Fardeau C., et al.

EYE , cilt.36, sa.1, ss.29-43, 2022 (SCI-Expanded)

42. Pediatric Uveitis in Turkey: The National Registry Report II

YALÇINDAĞ F. N., Ozdal P., Ozyazgan Y., Batioglu F., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.31, sa.10, ss.1971-1977, 2022 (SCI-Expanded)

43. Multiple evanescent white dot syndrome (MEWDS): update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective

Papasavvas I., Mantovani A., Tugal-Tutkun I., Herbort C. P.

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION , cilt.11, sa.1, 2021 (ESCI)

44. Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis

Takase H., Acharya N. R., Babu K., Bodaghi B., Khairallah M., McCluskey P. J., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.105, sa.11, ss.1515-1519, 2021 (SCI-Expanded)

45. Patterns of cytomegalovirus retinitis at a tertiary referral center in Turkey

Sadik M. T., Aksu Ceylan N., Cebeci Z., Kir N., Oray M., Tugal-Tutkun I.

INTERNATIONAL OPHTHALMOLOGY , cilt.41, ss.2981-2992, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study

Kramer M., Brichova M., Tugal-Tutkun I., Panchenko M., Gormezano N., Koenigsbauer F., et al.

OPHTHALMOLOGY AND THERAPY , cilt.10, sa.3, ss.565-580, 2021 (SCI-Expanded)

47. Comparison of Sociodemographic Features Between Behcet Uveitis and Other Non-infectious Uveitis

YALÇINDAĞ F. N., Ozdal P. C., Ozyazgan Y., BATIOĞLU F., Tugal-Tutkun I.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.51, sa.4, ss.206-211, 2021 (ESCI)

48. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology

Degirmenci M. F. K., YALÇINDAĞ F. N., Tugal-Tutkun I.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.51, sa.4, ss.231-242, 2021 (ESCI) Sürdürülebilir Kalkınma

49. An Algorithm for the Diagnosis of Behcet Disease Uveitis in Adults

Tugal-Tutkun I., Onal S., Stanford M., AKMAN M., Twisk J. W. R., Boers M., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.29, sa.6, ss.1154-1163, 2021 (SCI-Expanded)

50. Classification of Non-Infectious and/or Immune Mediated Choroiditis: A Brief Overview of the Essentials

Herbort C. P., Mantovani A., Tugal-Tutkun I., Papasavvas I.

DIAGNOSTICS , cilt.11, sa.6, 2021 (SCI-Expanded)

51. Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: noninvasive imaging methods

Tugal-Tutkun I., Herbort C. P., Mantovani A., Neri P., Khairallah M.

EYE , cilt.35, sa.1, ss.33-51, 2021 (SCI-Expanded)

52. Advances and potential new developments in imaging techniques for posterior uveitis Part 2: invasive imaging methods

Herbort C. P., Tugal-Tutkun I., Mantovani A., Neri P., Khairallah M., Papasavvas I.

EYE , cilt.35, sa.1, ss.52-73, 2021 (SCI-Expanded)

53. Multimodality Approach to the Diagnosis and Assessment of Uveitic Macular Edema

Khochtali S., Tugal-Tutkun I., Fardeau C., Maestri F., Khairallah M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, sa.8, ss.1212-1222, 2020 (SCI-Expanded)

54. Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis

Agarwal A., Agrawal R., Raje D., Testi I., Mahajan S., Gunasekeran D. V., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, ss.65-73, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

55. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis

Agrawal R., Betzler B., Testi I., Mahajan S., Agarwal A., Gunasekeran D. V., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, ss.17-26, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

56. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area

Herbort Jr C. P., Tugal-Tutkun I., Khairallah M., Abu el Asrar A. M., Pavesio C. E., Soheilian M.

INTERNATIONAL OPHTHALMOLOGY , cilt.40, sa.9, ss.2423-2433, 2020 (SCI-Expanded)

57. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population

Testi I., Agrawal R., Mahajan S., Agarwal A., Gunasekeran D. V., Raje D., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, sa.sup1, ss.58-64, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6

Agrawal R., Gunasekeran D. V., Agarwal A., Testi I., Carreno E., Westcott M., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, sa.sup1, ss.49-57, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

59. The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings

Agrawal R., Testi I., Mahajan S., Yuen Y. S., Agarwal A., Rousselot A., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, sa.sup1, ss.85-95, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

60. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis

Agrawal R., Betzler B. K., Testi I., Mahajan S., Agarwal A., Gunasekeran D. V., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.28, sa.sup1, ss.27-37, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

61. Behcet's disease uveitis: is there a need for new emerging drugs?

Tugal-Tutkun I., Ozdal P. C.

EXPERT OPINION ON EMERGING DRUGS , cilt.25, sa.4, ss.531-547, 2020 (SCI-Expanded)

62. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

Agrawal R., Agarwal A., Jabs D. A., Kee A., Testi I., Mahajan S., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

63. Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1

Testi I., Agrawal R., Mahajan S., Agarwal A., Gunasekeran D. V., Raje D., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Long-term Results of Trabeculectomy With Mitomycin-C in Patients With Bilateral Acute Iris Transillumination

Bayraktar S., Oray M., Altan C., Basarir B., Izgi B., Tugal-Tutkun I.

JOURNAL OF GLAUCOMA , cilt.28, sa.9, ss.797-802, 2019 (SCI-Expanded)

65. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1 A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis

Gunasekeran D. V., Agrawal R., Agarwal A., Carreno E., Raje D., Aggarwal K., et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES , cilt.39, sa.8, ss.1623-1631, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

66. Comparison of Retinal and Choroidal Involvement in Sarcoidosis-related Chorioretinitis Using Fluorescein and Indocyanine Green Angiography Reply

Herbort C. P., El Ameen A., Tugal-Tutkun I., Khairallah M.

JOURNAL OF OPHTHALMIC & VISION RESEARCH , cilt.14, sa.2, ss.237, 2019 (ESCI)

67. Biologic Treatment Options for Retinal Neovascularization in Behcet's Disease

Markomichelakis N. N., Aissopou E. K., Maselos S., Tugal-Tutkun I., Sfikakis P. P.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.27, sa.1, ss.51-57, 2019 (SCI-Expanded)

68. QUANTITATIVE ANALYSIS OF STRUCTURAL ALTERATIONS IN THE CHOROID OF PATIENTS WITH ACTIVE BEHCET UVEITIS

Onal S., Uludag G., Oray M., Mengi E., Herbort C. P., AKMAN M., et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES , cilt.38, sa.4, ss.828-840, 2018 (SCI-Expanded)

69. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report

YALÇINDAĞ F. N., Ozdal P. C., Ozyazgan Y., BATIOĞLU F., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.1, ss.17-26, 2018 (SCI-Expanded)

70. Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis

Tugal-Tutkun I., Cimino L., Akova Y. A.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.2, ss.171-177, 2018 (SCI-Expanded)

71. Varicell Zoster Virus-Associated Uveitis

Cunningham E. T., Miserocchi E., Tugal-Tutkun I., Zierhut M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.2, ss.167-170, 2018 (SCI-Expanded)

72. Whole-genome imputation study implicates TLR2 locus variants that confer risk for Behcet's disease by increasing innate immune response against microbes

Remmers F., Takeuchi M., Meguro A., Ombrello M. J., Kirino Y., Horita N., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

73. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality

HERBORT C. P., ABU EL ASRAR A. M., Yamamoto J. H., PAVESIO C. E., GUPTA V., KHAIRALLAH M., et al.

INTERNATIONAL OPHTHALMOLOGY , cilt.37, sa.6, ss.1383-1395, 2017 (SCI-Expanded)

74. Ophthalmic manifestations of bartonella infection

Amer R., Tugal-Tutkun I.

CURRENT OPINION IN OPHTHALMOLOGY , cilt.28, sa.6, ss.607-612, 2017 (SCI-Expanded)

75. The importance of quantitative measurement methods for uveitis: laser flare photometry endorsed in Europe while neglected in Japan where the technology measuring quantitatively intraocular inflammation was developed

Herbort C. P., Tugal-Tutkun I.

INTERNATIONAL OPHTHALMOLOGY , cilt.37, sa.3, ss.469-473, 2017 (SCI-Expanded)

76. Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis

Herbort C. P., Tugal-Tutkun I., Neri P., Pavesio C., Onal S., LeHoang P.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.33, sa.4, ss.263-277, 2017 (SCI-Expanded)

77. Treatment Results in Serpiginous Choroiditis and Multifocal Serpiginoid Choroiditis Associated with Latent Tuberculosis

Oray M., Zakiev Z., Cagatay T., Tugal-Tutkun I.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.47, sa.2, ss.89-93, 2017 (ESCI) Sürdürülebilir Kalkınma

78. Inflammatory eye disease: Pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: Recommendations from an expert committee

Wakefield D., McCluskey P., Wildner G., Thurau S., Carr G., Chee S., et al.

AUTOIMMUNITY REVIEWS , cilt.16, sa.3, ss.213-222, 2017 (SCI-Expanded)

79. Behcet Uveitis

Cunningham E. T., Tugal-Tutkun I., Khairallah M., Okada A. A., Bodaghi B., Zierhut M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.1, ss.2-6, 2017 (SCI-Expanded)

80. Systemic vasculitis and the eye

Tugal-Tutkun I.

CURRENT OPINION IN RHEUMATOLOGY , cilt.29, sa.1, ss.24-32, 2017 (SCI-Expanded)

81. Challenges of Diagnosing Viral Anterior Uveitis

Groen-Hakan F., Babu K., Tugal-Tutkun I., Pathanapithoon K., de Boer J. H., Smith J. R., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.5, ss.715-725, 2017 (SCI-Expanded)

82. Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded)

83. **HOMOZYGOSITY FOR A SINGLE ERAP1 ALLOTYPE GREATLY INCREASES BEHCET'S DISEASE RISK IN HLA-B*51 CARRIERS**

Remmers E. F., Takeuchi M., Ombrello M. J., Kirino Y., Erer B., Tugal-Tutkun I., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

84. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

85. Novel Susceptible Genes for Behcet's Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Kirino Y., Satorius C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

86. Uveitis in Children and Adolescents

Cunningham E. T., Smith J. R., Tugal-Tutkun I., Rothova A., Zierhut M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.24, sa.4, ss.365-371, 2016 (SCI-Expanded)

87. Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD

Kone-Paut I., Shahram F., Darce-Bello M., Cantarini L., Cimaz R., Gattorno M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.6, ss.958-964, 2016 (SCI-Expanded)

88. Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis

Oray M., Tugal-Tutkun I.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.46, sa.2, ss.77-82, 2016 (ESCI) Sürdürülebilir Kalkınma

89. Behcet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria

AKMAN-DEMIR G., Mutlu M. O., KIYAT-ARAMER A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded)

90. Natural killer cells dominate a Th-1 polarised response in Behcet's disease patients with uveitis

Kucuksezer U. C., Aktas-Cetin E., Bilgic-Gazioglu S., Tugal-Tutkun I., Gül A., Deniz G.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

91. Dexamethasone intravitreal implant (Ozurdex(A (R))) for pediatric uveitis

Sella R., Oray M., Friling R., UMAR L., Tugal-Tutkun I., Kramer M.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.253, sa.10, ss.1777-1782, 2015 (SCI-Expanded)

92. Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a

Aydinoglu-Candan O., Araz-Ersan B., Gül A., Badur S., Tugal-Tutkun I.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.253, sa.3, ss.457-465, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Bilateral acute iris transillumination following a fumigation therapy: a village-based traditional method for the treatment of ophthalmomyiasis

Gonul S., Bozkurt B., Okudan S., Tugal-Tutkun I.

CUTANEOUS AND OCULAR TOXICOLOGY , cilt.34, sa.1, ss.80-83, 2015 (SCI-Expanded)

94. Nonglaucomatous localized retinal nerve fiber layer defects in Behçet uveitis.

Oray M., ONAL S., Bayraktar Ş., Izgi B., Tugal-Tutkun I.

American journal of ophthalmology , cilt.159, sa.3, 2015 (SCI-Expanded)

95. Acute granulomatous iridocyclitis in a child with tubulointerstitial nephritis and uveitis syndrome

Barut K., Rzayev T., Canpolat N., Ozluk Y., Tugal-Tutkun I., Kasapcopur O.

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION , cilt.5, 2015 (ESCI)

96. Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study

Riemens A., BROMBERG J., TOUITOU V., SOBOLEWSKA B., MISSOTTEN T., BAARSMA S., et al.

JAMA OPHTHALMOLOGY , cilt.133, sa.2, ss.191-197, 2015 (SCI-Expanded)

97. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Kurtuncu M., Kiyat-Atamer A., Coban A., Akman-Demir G., et al.

MULTIPLE SCLEROSIS JOURNAL , sa.1, ss.105-107, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

98. Update on Uveitis Management

Gupta V., Nguyen Q. D., Zierhut M., Tugal-Tutkun I.

JOURNAL OF OPHTHALMOLOGY , 2015 (SCI-Expanded)

99. Validity and Agreement of Uveitis Experts in Interpretation of Ocular Photographs for Diagnosis of Behcet Uveitis

Tugal-Tutkun I., Onal S., Ozyazgan Y., Soylu M., AKMAN M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.22, sa.6, ss.461-468, 2014 (SCI-Expanded)

100. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)

Onal S., Tugal-Tutkun I.

OPHTHALMOLOGY , cilt.121, sa.10, 2014 (SCI-Expanded)

101. Evaluation of KIR3DL1/KIR3DS1 Association with Behcet's Disease in Turkish Individuals.

Erer B., Remmers E. F., Takeuchi M., Satorius C., Ustek D., Tugal-tutkun I., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

102. Vogt-Koyanagi-Harada Disease

Cunningham E. T., Rathinam S. R., Tugal-Tutkun I., Muccioli C., Zierhut M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.22, sa.4, ss.249-252, 2014 (SCI-Expanded)

103. Intravitreal dexamethasone implant (Ozurdex) and photodynamic therapy for vasoproliferative retinal tumours.

Cebeci Z., Oray M., Tuncer S., Tutkun I. T., Kir N.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie , cilt.49, sa.4, 2014 (SCI-Expanded)

104. Identification of multiple genetic susceptibility loci for Behcet's disease

Takeuchi M., Mizuki N., Meguro A., Tugal-Tutkun I., Ozyazgan Y., Ohno S., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.55, sa.13, 2014 (SCI-Expanded)

105. Therapy of Ocular Behcet Disease

ZIERHUT M., ABU EL-ASRAR A. M., BODAGHI B., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.22, sa.1, ss.64-76, 2014 (SCI-Expanded)

106. Disease of the Year: Juvenile Idiopathic Arthritis-associated Uveitis-Classification and Diagnostic Approach

Tugal-Tutkun I., Quartier P., BODAGHI B.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.22, sa.1, ss.56-63, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

107. Üveitli Behçet Hastalarında Atak-Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırılması

KÜÇÜKSEZER U. C., TAHRALI İ., BİLGİÇ GAZİOĞLU S., ÇETİN E., GÜL A., TUTKUN N. İ., et al.

Deneysel Tıp Araştırma Enstitüsü Dergisi , cilt.3, sa.6, ss.23-28, 2013 (Hakemli Dergi)

108. Autoimmune retinopathies: a report of 3 cases.

Oray M., Kir N., Tuncer S., Onal S., Tugal-Tutkun I.

Ocular immunology and inflammation , cilt.21, sa.6, ss.424-33, 2013 (SCI-Expanded)

109. Differential Diagnosis of Behcet Uveitis

Tugal-Tutkun I., GUPTA V., CUNNINGHAM E. T.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.21, sa.5, ss.337-350, 2013 (SCI-Expanded)

110. Controversies in Juvenile Idiopathic Arthritis-associated Uveitis

ZIERHUT M., HEILIGENHAUS A., deBoer J., CUNNINGHAM E. T., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.21, sa.3, ss.167-179, 2013 (SCI-Expanded)

111. Choroidal neovascularization secondary to choroidal nevus simulating an inflammatory lesion

Tuncer S., Tugal-Tutkun I.

INDIAN JOURNAL OF OPHTHALMOLOGY , cilt.61, sa.6, ss.305-306, 2013 (SCI-Expanded)

112. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.20, ss.8134-8139, 2013 (SCI-Expanded)

113. Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Dick A. D., Tugal-Tutkun I., Foster S., ZIERHUT M., LIEW S. H. M., BEZLYAK V., et al.

OPHTHALMOLOGY , cilt.120, sa.4, ss.777-787, 2013 (SCI-Expanded)

114. **Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1**

Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

NATURE GENETICS , cilt.45, sa.2, ss.202-207, 2013 (SCI-Expanded)

115. Cellular Debris in the Anterior Vitreous in Silent Eyes of Behcet Patients as a Clue of Asymptomatic Ocular Involvement

Cingu A. K., Turkcu F. M., Yeniad B., Tugal-Tutkun I.

JOURNAL OF OPHTHALMOLOGY , 2013 (SCI-Expanded)

116. Comparison of Presenting Features and Three-year Disease Course in Turkish Patients with Behcet Uveitis Who Presented in the Early 1990s and the Early 2000s

Cingu A. K., ONAL S., URGANCIOGLU M., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.20, sa.6, ss.423-428, 2012 (SCI-Expanded)

117. Is ICGA Still Relevant in Inflammatory Eye Disorders? Why This Question Has to Be Dealt With Separately From Other Eye Conditions

Herbort C. P., Neri P., El Asrar A. A., Gupta V., Kestelyn P., Khairallah M., et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES , cilt.32, sa.9, ss.1701-1703, 2012 (SCI-Expanded)

118. Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

Gül A., Tugal-Tutkun I., Dınarello C. A., Reznıkov L., Esen B. A., Mırza A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.563-566, 2012 (SCI-Expanded)

119. Central Serous Chorioretinopathy, Corticosteroids, and Uveitis

KHAIRALLAH M., KAHLOUN R., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.20, sa.2, ss.76-85, 2012 (SCI-Expanded)

120. Controversies in Behcet Disease

WAKEFIELD D., CUNNINGHAM E. T., Tugal-Tutkun I., KHAIRALLAH M., Ohno S., ZIERHUT M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.20, sa.1, ss.6-11, 2012 (SCI-Expanded)

121. Bilateral Acute Iris Transillumination

Tugal-Tutkun I., Onal S., GARIP A., Taskapili M., Kazokoglu H., KADAYIFÇILAR S., et al.

ARCHIVES OF OPHTHALMOLOGY , cilt.129, sa.10, ss.1312-1319, 2011 (SCI-Expanded)

122. Assessment of anterior chamber inflammation after intravitreal bevacizumab injection in different ocular exudative diseases.

Yeniad B., Ayranci O., Tuncer S., Kir N., Ovali T., Tugal-Tutkun I., et al.

European journal of ophthalmology , cilt.21, sa.2, ss.156-61, 2011 (SCI-Expanded)

123. Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet's disease: an international cohort study of 110 patients. One-year follow-up data

KONE-PAUT I., DARCE-BELLO M., SHAHRAM F., GATTORNO M., CIMAZ R., ÖZEN S., et al.

RHEUMATOLOGY , cilt.50, sa.1, ss.184-188, 2011 (SCI-Expanded)

124. Controversies in Ocular Inflammation and Immunology Laser Flare Photometry

WAKEFIELD D., HERBORT C. P., Tugal-Tutkun I., ZIERHUT M.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.18, sa.5, ss.334-340, 2010 (SCI-Expanded)

125. Interobserver Agreement in Scoring of Dual Fluorescein and ICG Inflammatory Angiographic Signs for the Grading of Posterior Segment Inflammation

Tugal-Tutkun I., HERBORT C. P., KHAIRALLAH M., MANTOVANI A.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.18, sa.5, ss.385-389, 2010 (SCI-Expanded)

126. Recurrent anterior uveitis in Henoch Schonlein's vasculitis

Erer B., Kamali S., Cingu K., Kilicaslan I., Gül A., Inanc M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.10, ss.1377-1379, 2010 (SCI-Expanded)

127. INTERFERON-ALFA THERAPY IN TURKISH PATIENTS WITH BEHCET UVEITIS

Tugal-Tutkun I., Araz B., Aydinoglu-Candan O., Ersan M. C., Uludag G.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

128. AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY

Tugal-Tutkun I.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

129. SAFE, RAPID-ONSET, AND SUSTAINED BIOLOGICAL ACTIVITY OF IL-1BETA REGULATING ANTIBODY XOMA 052 IN RESISTANT UVEITIS OF BEHCET'S DISEASE: PRELIMINARY RESULTS OF A PILOT TRIAL

Gül A., Artim-Esen B., Solinger A., Giustino L., Tugal-Tutkun I.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

130. Clinical Features, Prognosis, and Treatment Results of Patients With Scleritis From 2 Tertiary Eye Care Centers in Turkey

Erkanli L., Akova Y. A., Guney-Tefekli E., Tugal-Tutkun I.

CORNEA , cilt.29, sa.1, ss.26-33, 2010 (SCI-Expanded)

131. A Cross-sectional and Longitudinal Study of Fuchs Uveitis Syndrome in Turkish Patients

Tugal-Tutkun I., Guney-Tefekli E., Kamaci-Duman F., Corum I.

AMERICAN JOURNAL OF OPHTHALMOLOGY , cilt.148, sa.4, ss.510-515, 2009 (SCI-Expanded)

132. Multiple Anterior and Posterior Chamber Pseudocysts in a 12-Year-Old Boy With Diffuse Infiltrating Retinoblastoma

Tuncer S., Peksayar G., Kebudi R., Tugal-Tutkun I., Buyukbabani N., Darendeliler E.

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS , cilt.46, sa.5, ss.312-316, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

133. Bilateral Acute Depigmentation of the Iris: Report of 26 New Cases and Four-year Follow-up of Two Patients

Tugal-Tutkun I., Araz B., Taskapili M., Akova Y. A., YALNIZ-AKKAYA Z., BERKER N., et al.

OPHTHALMOLOGY , cilt.116, sa.8, ss.1552-1557, 2009 (SCI-Expanded)

134. Degos' Disease

Cebeci Z., Tuncer S., Tugal-Tutkun I.

OPHTHALMOLOGY , cilt.116, sa.7, ss.1415, 2009 (SCI-Expanded)

135. Retrospective analysis of children with uveitis treated with infliximab.

Tugal-Tutkun I., Ayranci O., Kasapcopur O., Kir N.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus , cilt.12, sa.6, ss.611-3, 2008 (SCI-Expanded)

136. Demographic and Clinical Features of Uveitis in Tertiary Centers in Turkey

Kazokoglu H., Onal S., Tugal-Tutkun I., Mirza E., Akova Y., Ozyazgan Y., et al.

OPHTHALMIC EPIDEMIOLOGY , cilt.15, sa.5, ss.285-293, 2008 (SCI-Expanded)

137. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behcet uveitis

Tugal-Tutkun I., Cingu K., Kir N., Yeniad B., Urgancioglu M., Gül A.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.246, sa.8, ss.1169-1177, 2008 (SCI-Expanded)

138. Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?

Akman-Demir G., Ayranci O., Kurtuncu M., Vanli E. N., Mutlu M., Tugal-Tutkun I.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded)

139. PEDIATRIC NEURO-BEHCET'S SYNDROME

Akman-Demir G., Saip S., Uluduz D., Kurtuncu M., Seyahi E., Tugal-Tutkun I., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2008 (SCI-Expanded)

140. INFERIOR PERIPHERAL PEARL-LIKE PRECIPITATES: A SPECIFIC FINDING OF BEHCET UVEITIS

Tugal-Tutkun I., Bayraktar S. C., Corum I.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded)

141. Pro-inflammatory cellular immune response in Behçet's disease

KULABER A., Tugal-Tutkun I., YENTUER S. P., AKMAN-DEMIR G., KANEKO F., Guel A., et al.

Rheumatology International , cilt.27, sa.12, ss.1113-1118, 2007 (SCI-Expanded)

142. Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behcet disease

Tuncer S., YILMAZ S., URGANCIOGLU M., Tugal-Tutkun I.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.23, sa.4, ss.395-401, 2007 (SCI-Expanded)

143. Referral patterns, demographic and clinical features, and visual prognosis of Turkish patients with sarcoid uveitis

Tugal-Tutkun I., AYDIN-AKOVA Y., GUENEY-TEFELKLI E., AYNACI-KAHRAMAN B.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.15, sa.4, ss.337-343, 2007 (SCI-Expanded)

144. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure

KOCABAY G., Erelel M., Tutkun I. T., Ecder T.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE , cilt.10, sa.12, ss.1418-1419, 2006 (SCI-Expanded)

145. Results of interferon-alfa therapy in patients with Behcet uveitis

Tugal-Tutkun I., GUNEY-TEFEKLI E., URGANCIOGLU M.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.244, sa.12, ss.1692-1695, 2006 (SCI-Expanded)

146. Bilateral acute depigmentation of the iris

Tugal-Tutkun I., Urgancioglu M.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.244, sa.6, ss.742-746, 2006 (SCI-Expanded)

147. Neovascularization of the optic disc in Behcet's disease

Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., Kir N., Urgancioglu M.

JAPANESE JOURNAL OF OPHTHALMOLOGY , cilt.50, sa.3, ss.256-265, 2006 (SCI-Expanded)

148. Clinical features and outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population

Tuncer S., ADAM Y., URGANCIOGLU M., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.13, sa.5, ss.367-373, 2005 (SCI-Expanded)

149. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease - An open-label trial

Tugal-Tutkun I., MUDUN A., URGANCIOGLU M., Kamali S., KASAPOGLU E., Inanc M., et al.

ARTHRITIS AND RHEUMATISM , cilt.52, sa.8, ss.2478-2484, 2005 (SCI-Expanded)

150. Uveitis in Behcet disease: An analysis of 880 patients.

Tugal-Tutkun I., ONAL S., ALTAN-YAYCIOGLU R., ALTUNBAS H., URGANCIOGLU M.

AMERICAN JOURNAL OF OPHTHALMOLOGY , cilt.138, sa.3, ss.373-380, 2004 (SCI-Expanded)

151. Childhood-onset uveitis in Behcet disease: A descriptive study of 36 cases

Tugal-Tutkun I., URGANCIOGLU M.

AMERICAN JOURNAL OF OPHTHALMOLOGY , cilt.136, sa.6, ss.1114-1119, 2003 (SCI-Expanded)

152. Prevalence of Behçet's disease in Istanbul, Turkey.

Azizlerli G., Kose A., Sarica R., Gul A., Tutkun I., KULAC M., et al.

International journal of dermatology , cilt.42, sa.10, ss.803-6, 2003 (SCI-Expanded)

153. Conjunctival ulcers in Behcet's disease

Zamir E., Bodaghi B., Tugal-Tutkun I., See R., Charlotte F., Wang R., et al.

OPHTHALMOLOGY , cilt.110, sa.6, ss.1137-1141, 2003 (SCI-Expanded)

154. **Lack of association of HLA-B*51 with a severe disease course in Behcet's disease**

Gul A., UYAR F. A., Inanc M., Ocal L., Tugal-Tutkun I., Aral O., et al.

RHEUMATOLOGY , cilt.40, sa.6, ss.668-672, 2001 (SCI-Expanded)

155. Cytomegalovirus retinitis in a patient with Wegener's granulomatosis

Tugal-Tutkun I., Kir N., Gul A., KONICE M., URGANCIOGLU M.

OPHTHALMOLOGICA , cilt.214, sa.2, ss.149-152, 2000 (SCI-Expanded)

156. Long-term follow-up of patients with atopic keratoconjunctivitis

POWER W., Tugal-Tutkun I., FOSTER C.

OPHTHALMOLOGY , cilt.105, sa.4, ss.637-642, 1998 (SCI-Expanded)

157. An experimental study on the effect of collagen shields and therapeutic contact lenses on corneal wound healing.

Simsek N., Ay G., TugalTutkun I., Basar D., Bilgin L.

Cornea , cilt.15, sa.6, ss.612-6, 1996 (SCI-Expanded)

158. Changing patterns in uveitis of childhood.

TugalTutkun I., Havrlikova K., Power W., Foster C.

Ophthalmology , cilt.103, sa.3, ss.375-83, 1996 (SCI-Expanded)

159. Immunopathologic study of the conjunctiva in patients with behçet disease.

TUGALTUTKUN I., URGANCIOGLU M., FOSTER C.

Ophthalmology , cilt.102, sa.11, ss.1660-8, 1995 (SCI-Expanded)

160. Penetrating keratoplasty in cicatrizing conjunctival diseases.

TUGALTUTKUN I., AKOVA Y., FOSTER C.

Ophthalmology , cilt.102, sa.4, ss.576-85, 1995 (SCI-Expanded)

161. Corneal sensitivity after penetrating keratoplasty.

Tuğal T., Akarçay K., Közer B., Sansoy N., Urgancioğlu M.

European journal of ophthalmology , cilt.3, ss.66-70, 1993 (SCI-Expanded)

162. Binocular vision regained after monocular traumatic aphakia by wearing contact lenses.

Közer B., Pakter S., Sezen F., Tugal T.

European journal of ophthalmology , cilt.2, ss.86-90, 1992 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 24

1. Expert recommendations for management of ocular sarcoidosis

Takase H., Smith J. R., Acharya N., Thorne J. E., McCluskey P. J., Bodaghi B., et al.

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ELECTR NETWORK, 1 - 07 Mayıs 2020, cilt.61, (Özet Bildiri)

2. A New Threat for Tuberculosis: Biological Agents

KARA E. M., HANÇERLİ TÖRÜN S., KABA Ö., DUDAKLI A., ASGAROVA L., TURAN O., et al.

37th Annual Meeting of European Society for Paediatric Infectious Diseases, Ljubljana, Slovenya, 6 - 11 Mayıs 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

3. TERİFLUNOMİD TEDAVİSİNİN MULTİPL SKLEROZ İLE İLİŞKİLİ ÜVEİT ÜZERİNE ETKİSİ

GÜNDÜZ T., AKSU CEYLAN N., ORAY M., TUTKUN N. İ., KÜRTÜNCÜ M.

NÖRO-OFTALMOLOJİ NÖRO-OTOLOJİ SEMPOZYUMU, Türkiye, 22 - 24 Mart 2019

4. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

Takeuchi M., Mizuki N., Meguro A., Ombrello M., Tugal-tutkun I., Ozyazgan Y., et al.

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Washington, Amerika Birleşik Devletleri, 1 - 05 Mayıs 2016, cilt.57, (Özet Bildiri)

5. COGAN SYNDROME: DIFFERENTIAL RESPONSE TO BIOLOGIC AGENTS AND ROLE OF PET-CT IN THE INCREASED DIAGNOSIS OF AORTITIS

Toz B., Erer B., Kamali S., Tugal-Tutkun I., Ocal L., Gul A.

Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1208-1209, (Özet Bildiri)

6. Üveitin Multipl Sklerozun Seyri Üzerine Etkisi

SHUGAİV E., TÜZÜN E., ÇOBAN A., PEHLİVAN M., KÜRTÜNCÜ M., DEMİR G., et al.

49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

7. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., TÜZÜN E., ÇOBAN A., Pehlivan M., KÜRTÜNCÜ M., Demir G., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

8. Otoimmun retinopati olgusunda rituksimab tedavisi sonuçları

AKSU CEYLAN N., ORAY M., TUTKUN N. İ.

TOD 48. ULUSAL KONGRESİ, Türkiye, 5 - 09 Kasım 2014

9. Cerebral white matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., KÜRTÜNCÜ M., Tugal-Tutkun I., et al.

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.948-949, (Özet Bildiri)

10. IL 21 Reseptor Genindeki Mutasyon İle İlşikili Primer İmmun Yetersizlik Olgusu

HANÇERLİ TÖRÜN S., SOMER A., ışın b., merih o., çalışkan b., AKTÜRK H., et al.

9.Ulusal Çocuk Alerji ve Astım Kongresi, Türkiye, 23 - 26 Nisan 2014

11. Acute Retinal Necrosis: Worse Prognosis Due to Late Referrral.

Oray M., Aksu Ceylan N., Altınkurt E., Kır N., Tutkun N. İ.

World Ophthalmology Congress 2014, Tokyo, Japonya, 2 - 06 Nisan 2014, (Özet Bildiri)

12. Cytomegalovirus Retinitis in Immunosuppressed Patients

SOMER A., SÜTÇÜ M., BULUT M., ORAY M., TUTKUN N. İ., HANÇERLİ TORUN S., et al.

8th World Congress of the World Society for Pediatric Infectious Diseases, Güney Afrika, 19 - 22 Kasım 2013

13. cytomegalovirus retinitis in immunsuppresssed patients

SOMER A., SÜTÇÜ M., bulut m., merih o., TUTKUN N. İ., SALMAN N., et al.

8th world congress of the world society for pediatric infectious disease, Güney Afrika, 19 - 22 Kasım 2013

14. Effect of Cataract Surgery on Eyes with Uveitis

Oray M., Gözüm N., Tutkun N. İ., Yıldız Taş A.

American Academy of Ophthalmology, Louisiana, Amerika Birleşik Devletleri, 16 - 19 Kasım 2013, ss.1-2, (Özet Bildiri)

15. Akut Retinal Nekroz: Erken tanı ve tedavinin önemi

Aksu Ceylan N., Oray M., Altınkurt E., Tutkun N. İ., Kır N.

TOD 47. Ulusal Kongresi, Antalya, Türkiye, 6 - 10 Kasım 2013, (Özet Bildiri)

16. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Coban A., Pehlivan M., Kurtuncu M., Tugal-Tutkun I., et al.

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, ss.352, (Özet Bildiri)

17. High Density Genotyping Of Immune-Related Disease Genes Identifies 7 New Susceptibility Loci For Behcets Disease

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Satorius C., Kirino Y., et al.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

18. Uveitis in patients with multiple sclerosis

Shugaiv E., Kurtuncu M., Mutlu M., Akman-Demir G., Tugal-Tutkun I., Tuzun E., et al.

28th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Lyon, Fransa, 10 - 13 Ekim 2012, cilt.18, ss.258

19. White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, Amerika Birleşik Devletleri, 21 - 28 Nisan 2012, cilt.78, (Özet Bildiri)

20. Recurrent exudative retinal detachment in a patient with Vogt- Koyonagi- Harada Disease

Altınkurt E., Kardeş E., Tutkun N. İ.

The Second Meeting of the Society for Ophthalmo-Immunoinfectiology in Europe, Kayseri, Türkiye, 12 - 15 Haziran 2018, ss.47, (Özet Bildiri)

21. 111 Hastada Herpetik Ön Üveit

Ötük B., Altınkurt E., Tutkun N. İ.

TOD 41. Ulusal Oftalmoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2007, (Özet Bildiri)

22. RETROSPECTIVE STUDY OF 111 PATIENTS WITH HERPETIC ANTERIOR UVEITIS

Öztük B., Altınkurt E., Tutkun N. İ.

9th International Ocular Inflammation Society (IOIS) Congress, Paris, Fransa, 17 - 20 Eylül 2007, ss.80, (Özet Bildiri)

23. Cyclosporine A treatment for ocular involvement of Behcet's disease: is it associated with an increased risk of neurological involvement?

AKMAN-DEMIR G., DEMIR G., AYRANCI O., VANLI E. N., MUTLU M., KURTUNCU M., et al.

17th Meeting of the European-Neurological-Society, Rhodes, Yunanistan, 16 - 20 Haziran 2007, cilt.254, ss.60-61

24. Efficacy of infliximab in the treatment of uveitis resistant to the combination of azathioprine and cyclosporin in Behcet's disease: Preliminary report of an open trial

Tugal-Tutkun I., Gul A., Mudun A., Inanc M., Kamali S., Urgancioglu M.

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology, Florida, Amerika Birleşik Devletleri, 24 - 29 Nisan 2004, cilt.45, (Özet Bildiri)

Metrikler

Yayın

186

Yayın (WoS)

169

Yayın (Scopus)

161

Atıf (WoS)

3432

H-İndeks (WoS)

Atıf (Scopus)

4085

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler